Sulfasalazine attenuates evading anticancer response of CD133-positive hepatocellular carcinoma cells
Sulfasalazine attenuates evading anticancer response of CD133-positive hepatocellular carcinoma cells Abstract Background CD133-positive cells in hepatocellular carcinoma (HCC) display cancer stem cell (CSC)-like properties in addition to resistance to chemotherapeutic agents and radiation that is ionizing but, their function remains unknown. In this paper, we identified a hitherto unknown procedure to overcome CD133-induced resistance to …